ISIS PHARMACEUTICALS INC
CIK 874015 · View on SEC EDGAR ↗
First SEC filing: July 13, 2017 · Latest: July 13, 2017
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 10, 2020 | IONS | P | 21,237,715 | $18.15 | $385,464,527 | 98,322,397 Indirect | +27.55% | Acquired | 227.6% (price as of 2026-08-20) |
| April 17, 2018 | IONS | P | 10,666,666 | $18.75 | $199,999,988 | 64,114,545 Direct | +19.96% | Acquired | 217.1% (price as of 2026-08-20) |
| July 19, 2017 | IONS | P | 3,125,000 | $8.00 | $25,000,000 | 45,447,879 Direct | +7.38% | Acquired | 643.3% (price as of 2026-08-20) |
| July 17, 2015 | IONS | S | 111,000 | $10.21 | $1,133,310 | 5,173,172 Direct | -2.10% | Disposed | 482.4% (price as of 2026-08-20) |
| July 16, 2015 | IONS | S | 167,000 | $10.79 | $1,801,930 | 5,284,172 Direct | -3.06% | Disposed | 451.1% (price as of 2026-08-20) |
| July 15, 2015 | IONS | S | 65,133 | $10.76 | $700,831 | 5,451,172 Direct | -1.18% | Disposed | 452.6% (price as of 2026-08-20) |
| June 30, 2015 | IONS | S | 13,248 | $10.79 | $142,946 | 5,516,305 Direct | -0.24% | Disposed | 451.1% (price as of 2026-08-20) |
| Oct. 24, 2014 | IONS | S 10b5-1 | 446 | $16.29 | $7,265 | 6,795,716 Direct | -0.01% | Disposed | 265.0% (price as of 2026-08-20) |
| Oct. 24, 2014 | IONS | S 10b5-1 | 350 | $15.50 | $5,425 | 6,796,162 Direct | -0.01% | Disposed | 283.6% (price as of 2026-08-20) |
| Oct. 24, 2014 | IONS | S 10b5-1 | 1,054 | $14.63 | $15,420 | 6,796,512 Direct | -0.02% | Disposed | 306.4% (price as of 2026-08-20) |
| Oct. 23, 2014 | IONS | S 10b5-1 | 50 | $15.45 | $772 | 6,797,566 Direct | 0.00% | Disposed | 284.9% (price as of 2026-08-20) |
| Oct. 23, 2014 | IONS | S 10b5-1 | 450 | $14.90 | $6,705 | 6,797,616 Direct | -0.01% | Disposed | 299.1% (price as of 2026-08-20) |
| Oct. 23, 2014 | IONS | S 10b5-1 | 1,200 | $13.94 | $16,728 | 6,798,066 Direct | -0.02% | Disposed | 326.5% (price as of 2026-08-20) |
| Oct. 22, 2014 | IONS | S 10b5-1 | 175 | $17.11 | $2,994 | 6,799,266 Direct | 0.00% | Disposed | 247.5% (price as of 2026-08-20) |
| Oct. 22, 2014 | IONS | S 10b5-1 | 11,376 | $16.59 | $188,728 | 6,799,441 Direct | -0.17% | Disposed | 258.4% (price as of 2026-08-20) |
| Oct. 22, 2014 | IONS | S 10b5-1 | 15,156 | $14.67 | $222,339 | 6,810,817 Direct | -0.22% | Disposed | 305.3% (price as of 2026-08-20) |
| Oct. 22, 2014 | IONS | S 10b5-1 | 57,753 | $13.91 | $803,344 | 6,825,973 Direct | -0.84% | Disposed | 327.5% (price as of 2026-08-20) |
| Oct. 22, 2014 | IONS | S 10b5-1 | 15,791 | $12.83 | $202,599 | 6,883,726 Direct | -0.23% | Disposed | 363.4% (price as of 2026-08-20) |
| Oct. 22, 2014 | IONS | S 10b5-1 | 9,283 | $12.18 | $113,067 | 6,899,517 Direct | -0.13% | Disposed | 388.2% (price as of 2026-08-20) |
| Oct. 10, 2012 | IONS | P | 750,000 | $4.00 | $3,000,000 | 7,049,500 Direct | +11.91% | Acquired | 1386.5% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 19, 2017 | IONS | Series A Preferred Stock | Common Stock (28,884,540) | — | — | 28,884,540 | Disposed |
| Oct. 10, 2012 | IONS | Series A Preferred Stock | Common Stock (6,299,500) | — | — | 6,299,500 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.